.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
AstraZeneca
Citi
Argus Health
Cantor Fitzgerald
McKinsey
Johnson and Johnson
Merck
Moodys
Novartis

Generated: September 20, 2017

DrugPatentWatch Database Preview

Iodohippurate sodium i-131 - Generic Drug Details

« Back to Dashboard

What are the generic sources for iodohippurate sodium i-131 and what is the scope of iodohippurate sodium i-131 patent protection?

Iodohippurate sodium i-131
is the generic ingredient in three branded drugs marketed by Pharmalucence, Bracco, and Mallinckrodt, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: iodohippurate sodium i-131

Tradenames:3
Patents:0
Applicants:3
NDAs:3
Clinical Trials: see list2,552
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:iodohippurate sodium i-131 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
HIPPUTOPE
iodohippurate sodium i-131
INJECTABLE;INJECTION015419-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt
HIPPURAN I 131
iodohippurate sodium i-131
INJECTABLE;INJECTION016666-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmalucence
IODOHIPPURATE SODIUM I 131
iodohippurate sodium i-131
INJECTABLE;INJECTION017313-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Moodys
Queensland Health
AstraZeneca
US Department of Justice
Teva
Healthtrust
Covington
Novartis
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot